Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500109438Phase 4Not yet recruiting
Phase 4, randomised trial of remimazolam in sleep disorder (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoint: Quality of sleep. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500109438.